Cargando…
Dialyzable Leukocyte Extract (Transferon™) Administration in Sepsis: Experience from a Single Referral Pediatric Intensive Care Unit
Immunomodulatory agents have been proposed as therapeutic candidates to improve outcomes in sepsis. Transferon™, a dialyzable leukocyte extract (DLE), has been supported in Mexico as an immunomodulatory adjuvant in anti-infectious therapy. Here we present a retrospective study describing the experie...
Autores principales: | Castrejón Vázquez, Maria Isabel, Reséndiz-Albor, Aldo Arturo, Ynga-Durand, Mario A., Arciniega Martínez, Ivonne Maciel, Orellana-Villazon, Vanessa Ivonne, García López, Carlos Alberto, Laue Noguera, Maria Laura, Vargas Camaño, Maria Eugenia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612374/ https://www.ncbi.nlm.nih.gov/pubmed/31341910 http://dx.doi.org/10.1155/2019/8980506 |
Ejemplares similares
-
Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®)
por: Mellado-Sánchez, Gabriela, et al.
Publicado: (2019) -
Temporal Dynamics of T Helper Populations in the Proximal Small Intestine after Oral Bovine Lactoferrin Administration in BALB/c Mice
por: Ynga-Durand, Mario, et al.
Publicado: (2021) -
CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with LPS and Dialyzable Leukocyte Extract (Transferon®)
por: Jiménez-Uribe, Alexis P., et al.
Publicado: (2019) -
Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract “Transferon Oral”: The Starting Point to Understand Its Mechanism of Action
por: Vallejo-Castillo, Luis, et al.
Publicado: (2020) -
Physicochemical Characteristics of Transferon™ Batches
por: Medina-Rivero, Emilio, et al.
Publicado: (2016)